Adenosquamous cancer of the pancreas: A multicenter retrospective study

Ramia-Angel, José Manuel; Jaén-Torrejimeno, Isabel; Serrablo-Requejo, Alejandro; Rodríguez-Laiz, Gonzalo P; López-Guerra, Diego; Abadía-Forcén, Teresa; Alenda, Cristina; Serradilla-Martín, Mario; Blanco-Fernández, Gerardo.
Gastroenterol. hepatol. (Ed. impr.) ; 45(7): 543-551, Ago - Sep 2022. graf, ilus, tab
Artículo en Inglés | IBECS (España) | ID: ibc-206913

Documentos relacionados

  1. Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis.
  2. Pancreatic cancer: Advances and challenges.
  3. [Pay attention to whole cycle management of pancreatic cancer].
  4. Adenosquamous cancer of the pancreas: A multicenter retrospective study.
  5. Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12 months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoperative adjuvant chemotherapy S-1 (PACS-1) trial.
  6. Management of Patients With Pancreatic Cancer Using the "Right Track" Model.
  7. Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches.
  8. [Standardized implementation of multi-disciplinary treatment to improve the overall efficacy of pancreatic cancer].
  9. Association between BRCA Gene Variants and the Response to Modified FOLFIRINOX in Patients with Unresectable Pancreatic Cancer.
  10. Pancreatic Cancer Multidisciplinary Clinic is Associated with Improved Treatment and Elimination of Socioeconomic Disparities.